Endometritis
Welcome,         Profile    Billing    Logout  
 3 Companies   0 Products   0 Products   0 Mechanisms of Action   0 Trials   36 News 
  • ||||||||||  Trial completion, Trial primary completion date:  The Role of Novel Organisms in Acute Endometritis (clinicaltrials.gov) -  Aug 17, 2016   
    P=N/A,  N=480, Completed, 
    Not yet recruiting --> Recruiting Enrolling by invitation --> Completed | Trial primary completion date: Aug 2014 --> Aug 2015
  • ||||||||||  Betadine (povidone iodine) / Egis
    Enrollment change, Trial withdrawal:  CAPISSI: Prevention of Surgical Site Infection After Cesarean Delivery (clinicaltrials.gov) -  Jan 15, 2016   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Feb 2015 --> Dec 2015 N=4500 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Betadine (povidone iodine) / Egis
    Trial initiation date:  CAPISSI: Prevention of Surgical Site Infection After Cesarean Delivery (clinicaltrials.gov) -  Jan 28, 2015   
    P=N/A,  N=4500, Not yet recruiting, 
    N=2844 --> 0 | Not yet recruiting --> Withdrawn Initiation date: Feb 2014 --> Jun 2015
  • ||||||||||  clindamycin phosphate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  TUPAC: Treatment Utility of Postpartum Antibiotics in Chorioamnionitis (clinicaltrials.gov) -  Dec 10, 2014   
    P4,  N=80, Terminated, 
    Initiation date: Feb 2014 --> Jun 2015 N=238 --> 80 | Recruiting --> Terminated | Trial primary completion date: Jul 2013 --> Jul 2014; Futility in patient enrollment
  • ||||||||||  Invanz (ertapenem) / Merck (MSD)
    Trial termination:  Pharmacokinetics and Safety of Ertapenem in the Postpartum Period (clinicaltrials.gov) -  Jan 21, 2014   
    P1,  N=3, Terminated, 
    Recruiting --> Completed Recruiting --> Terminated; study terminated due to low subject accrual